Quick Listen: Scrip's Five Must-Know Things

In this week's podcast edition of Five Must-Know Things: alarms sound over Omicron; Sanofi boosts vaccine pipeline via acquisition; J&J’s immunology plans; Chinese firms step onto world stage; and top execs share insights to shape India’s R&D push.

audio roundup of global biopharma insights

Join us for an audio catch-up on the major events in the biopharma industry over the past business week, as reported by Scrip's global team, in this podcast version of Five Must-Know Things.

This episode covers insights for the business week ended 3 December 2021, including: alarms sound over Omicron; Sanofi boosts vaccine pipeline via acquisition; Johnson & Johnson’s immunology plans; Chinese firms step onto world stage; and top execs share insights to shape India’s R&D push.

This and all our other podcasts are available on the Informa Pharma Intelligence channel on Apple Podcasts, Google Podcasts, SoundCloud, TuneIn and Spotify Podcasts, and via smart speakers if one of these platforms has been set up as your default podcast provider.  

Stories mentioned in this episode:

(Also see "COVID-19 Vaccine Makers Pledge Rapid Response To Omicron Threat" - Scrip, 29 Nov, 2021.)

 

(Also see "Sanofi Adds To Vaccine Pipeline With Origimm Acquisition" - Scrip, 1 Dec, 2021.)

(Also see "J&J's Next Immunology Act Centers On Nipocalimab For Autoantibody-Driven Diseases" - Scrip, 26 Nov, 2021.)

(Also see "Chinese Biotechs Step Onto World Stage With Innovative Products, Competitive Prices" - Scrip, 26 Nov, 2021.)

(Also see "Evotec, Takeda Execs’ Big Picture Insights To Shape India’s R&D Push" - Scrip, 29 Nov, 2021.)

Open Media